Article
Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model.
Science translational medicine - 4 Sept 2013
Das Ishita, Park Joo-Min, Shin Jung H, Jeon Soo Kyeong, Lorenzi Hernan, Linden David J, Worley Paul F, Reeves Roger H
Abstract excerpt
Down syndrome (DS) is among the most frequent genetic causes of intellectual disability, and ameliorating this deficit is a major goal in support of people with trisomy 21. The Ts65Dn mouse recapitulates some major brain structural and behavioral phenotypes of DS, including reduced size and cellu...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
